Drugs / lactoserum
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials | ||||||
| Phase 3 | NCT00397527 | Jul 2006 → ? | — | Sanofi | Completed | No outcome recorded |
| Phase 3 | NCT00370162 | Jun 2006 → ? | — | Sanofi | Completed | No outcome recorded |
| Phase 3 | NCT00371852 | May 2006 → ? | — | Sanofi | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT00556179 | Sep 2007 → Dec 2008 | bacterial vaginosis | Sanofi | Completed | No outcome recorded |
| Phase 4 | NCT00497783 | May 2007 → ? | — | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lactoserum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00370162 ↗ |
| Known as | Dermacyd Femina | “Lactoserum (Dermacyd Femina®)” NCT00556179 ↗ |